A case report of zoledronic acid-induced bilateral conjunctivitis

Authors

  • Aishwaraya K. Department of Ophthalmology, Southern railways headquarters hospital, Perambur, Chennai, India
  • Suresh K. Department of Ophthalmology, Southern railways headquarters hospital, Perambur, Chennai, India
  • Saravanan R. Department of Ophthalmology, Southern railways headquarters hospital, Perambur, Chennai, India
  • Kannan M. Department of Ophthalmology, Southern railways headquarters hospital, Perambur, Chennai, India

DOI:

https://doi.org/10.18203/2349-2902.isj20250156

Keywords:

Zolendronate, Conjunctivitis, Fuorometholone

Abstract

Zoledronic acid is used to treat patients with osteoporosis, Paget’s disease, multiple myeloma, and several bone tumors. This is to report a case of a patient with cervical spondylosis with periorbital swelling, watering, diminution of vision, and redness in both eyes after zoledronate infusion. The patient had lid edema and conjunctival congestion in both eyes. Symptoms resolved after 10 days of fluorometholone eye drops. Bilateral conjunctivitis is a rare complication of zoledronic acid. Zoledronic acid causes T-cell activation leading to the release of cytokines and inflammatory mediators. Orbital inflammation, scleritis, and acute anterior uveitis have also been reported as side effects of zoledronic acid.

Metrics

Metrics Loading ...

References

Gupta S, Onkar A, Vashisht T. Zoledronic acid induced unilateral anterior uveitis. Indian J Ophthalmol. 2020;68(9):2002-3. DOI: https://doi.org/10.4103/ijo.IJO_1654_19

Zhu W, Xu R, Du J, Fu Y, Li S, Zhang P. Zoledronic acid promotes TLR‐4‐mediated M1 macrophage polarization in bisphosphonate‐related osteonecrosis of the jaw. FASEB J. 2019;33(4):5208-19. DOI: https://doi.org/10.1096/fj.201801791RR

Drake MT, Clarke BL, Khosla S. Bisphosphonates: Mechanism of Action and Role in Clinical Practice. Mayo Clin Proc Mayo Clin. 2008;83(9):1032-45. DOI: https://doi.org/10.4065/83.9.1032

Fraunfelder FW, Fraunfelder FT, Jensvold B. Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol. 2003;135(2):219-22. DOI: https://doi.org/10.1016/S0002-9394(02)01840-8

Peterson JD, Bedrossian EH. Bisphosphonate-associated orbital inflammation-a case report and review. Orbit Amst Neth. 2012;31(2):119-23. DOI: https://doi.org/10.3109/01676830.2011.648818

Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809-22. DOI: https://doi.org/10.1056/NEJMoa067312

Rathnam KK, Sagar TG, Cyriac S. Acute uveitis following zoledronic acid infusion. Oman J Ophthalmol. 2009;2(2):102-3. DOI: https://doi.org/10.4103/0974-620X.53046

Ryan PJ, Sampath R. Idiopathic orbital inflammation following intravenous pamidronate. Rheumatol Oxf Engl. 2001;40(8):956-7. DOI: https://doi.org/10.1093/rheumatology/40.8.956

Downloads

Published

2025-01-28

How to Cite

K., A., K., S., R., S., & M., K. (2025). A case report of zoledronic acid-induced bilateral conjunctivitis. International Surgery Journal, 12(2), 240–242. https://doi.org/10.18203/2349-2902.isj20250156

Issue

Section

Case Reports